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This paper explores the major challenges to the 
sustainability of health sector financing in the 
countries of the Western Balkans – Albania, Bosnia 
and Herzegovina, the Former Yugoslav Republic of 
Macedonia, Montenegro, Serbia and the province 
of Kosovo. It focuses on how the incentives created 
by the different elements of the healthcare financing 
system affect the behavior of healthcare providers and 
individuals, and the resulting inefficiencies in revenue 
collection and expenditure containment. The paper 
analyzes patterns of healthcare expenditure, finding that 
This paper—a product of the Health, Nutrition and Population Division, Human Development Department of the Europe 
and Central Asia Region—is part of a larger effort in the department to understand issues of efficiency and sustainability 
of health financing in the countries of the Western Balkans. Policy Research Working Papers are also posted on the Web at 
http://econ.worldbank.org. The authors may be contacted at cbredenkamp@worldbank.org and mgragnolati@worldbank.
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there is some evidence of cost containment, but that 
current expenditure levels – while similar to that in EU 
countries as a share of GDP – are low in per capita terms 
and the fiscal space to increase expenditures is extremely 
limited. It also examines the key drivers of current 
healthcare expenditure and the most significant barriers 
to revenue generation, identifying some key health 
reforms that countries in the sub-region could consider 
in order to enhance the efficiency and sustainability of 
their health systems. Data are drawn from international 
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The five Western Balkan countries – Albania, Bosnia and Herzegovina, the Former Yugoslav 
Republic (FYR) of Macedonia, Montenegro, and Serbia – and the province of Kosovo
1 have 
undergone significant transitions in the past decade or two, which have been complicated by a 
series of regional conflicts. After an initial phase focused on macroeconomic stabilization and 
reconstruction, reforms are now focusing on enhancing economic growth, promoting employment 
generation, and encouraging the containment and efficiency of public spending. The countries’ 
shared aspiration to join the European Union (EU) exerts an important influence on policy 
decisions. 
 
In the health sector, the main challenge is to continue to make progress towards achieving health 
system objectives, namely improving population health status and providing protection against 
the financial costs of illness, while ensuring the financial sustainability of the health sector.  
 
This paper explores the major challenges to the sustainability of health sector financing in the 
Western Balkans, both on the revenue and the expenditure side, and identifies measures that can 
be taken to enhance it. It focuses on those elements that are endogenous to the healthcare 
financing system and that are amenable to improvement through government-led reforms, rather 
than exogenous elements such as demographic change and fiscal pressures. In so doing it 
examines the incentives created by the different elements of the healthcare financing system 
(such as the revenue collection system and the provider payment mechanism) and the effect that 
these incentives have on the behavior of healthcare providers, firms, and individuals, and the 
resultant inefficiencies. The central thesis is that, although countries in the Western Balkans have 
succeeded in containing the growth in public expenditure on health during the past few years, in 
future more efficient management of revenue collection and spending will be needed if countries 
are to steer their health systems towards attaining their objectives, while meeting the obligation of 
fiscal sustainability.  
 
The structure of the paper is as follows: After describing the geographical scope of the analysis 
and the limitations of the data, the main patterns and historical trends in the sources of health care 
financing are presented, and the key challenges that the health systems face in ensuring sufficient 
revenue generation are discussed. Then, current and past expenditure patterns are described and 
the effects of the structure of the healthcare financing system on the magnitude and efficiency of 
health expenditures are explored. The paper concludes by summarizing some of the key health 
sector reforms that countries in the Western Balkans could consider in order to enhance the 
effectiveness and sustainability of their health systems. 
 
B. GEOGRAPHICAL SCOPE, DATA SOURCES AND LIMITATIONS 
B1 Geographical scope 
 
This paper defines the Western Balkans as the five South Eastern European countries of Albania, 
Bosnia and Herzegovina, the Former Yugoslav Republic of Macedonia, Montenegro and Serbia, 
                                                 
1 Kosovo is a province of Serbia under the autonomous administration of the United Nations. For the 
purposes of this paper, it is treated as a separate unit of analysis.   4
and the province of Kosovo
2. With the exception of Albania, all of these countries were part of 
the former Socialist Federal Republic of Yugoslavia (SFRY).  
 
Throughout the paper comparisons will be made with the financing and expenditure patterns in 
the EU-15
3 and EU-12
4 countries. Explicit comparisons will also be made with Croatia and 
Slovenia. They are useful comparators because they were originally part of the SFRY, seceding in 
1991, and have shared common aspirations of joining the EU
5.   
B2 Data sources 
 
The data used in this report are drawn from a number of sources: 
 
(i)  International databases: The World Bank’s World Development Indicators 2007 
database (WDI 2007) is the main source of health expenditure data
6. For certain 
estimates that are not available in the WDI database, the World Health 
Organization’s (WHO) Health for All 2007 database (HFA-DB 2007) is used. Most 
of the information on revenue sources is obtained from the WHO National Health 
Accounts (NHA) database.  
(ii)  Country institutions: This report also relies on information provided to the World 
Bank by country institutions, such as ministries of health, ministries of finance, 
statistical institutes and institutes of public health. Some of this information has been 
published in World Bank reports, including poverty assessments, country and sector 
studies, and public expenditure and institutional reviews. These information sources 
are particularly valuable for data on Serbia, Montenegro and Kosovo for which 
revenue and expenditure information is not yet available in the major databases.  
(iii)  Household surveys: Data on private out-of-pocket expenditure are mainly drawn 
from household surveys, conducted by governments or by statistical or international 
organizations, often with the support of the World Bank. These include the Living 
Standards and Measurements Survey (LSMS) and the Household Budget Survey 
(HBS). 
 
B3 Data limitations 
 
All of these sources are subject to certain limitations with respect to data availability and 
reliability, many of which are well-known and typical of the particular mode of data collection. In 
addition, the following limitations are of particular relevance to the data of the sub-region: 
                                                 
2 This definition of the Western Balkans reflects the World Bank’s operational classification of the sub-
regions of Europe and Central Asia.  
3 The EU-15 countries include all those that had joined the EU by 1995, namely Austria, Belgium, 
Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, the Netherlands, Portugal, 
Sweden, the United Kingdom and Spain. 
4 The EU-12 countries include those that joined the EU from May 2004 onwards, namely Bulgaria, Cyprus, 
the Czech Republic, Estonia, Hungary, Latvia, Lithuania, Malta, Poland, Romania, the Slovak Republic 
and Slovenia. 
5 Slovenia is already a member of the EU and Croatia, having signed a Stabilization and Association 
Agreement with the EU in 2005, is advancing towards full membership.     
6 Most of the WDI data are, in turn, derived from the latest WHO estimates, which are published in the 
WHO’s World Health Report 2006, and then supplemented by published and unpublished World Bank and 
International Monetary Fund (IMF) data.   5
(i)  Accuracy of population estimates: Population estimates, and thus all per capita 
estimates, are subject to a high degree of inaccuracy owing to mass migration 
movements associated with sub-regional conflicts, as well as incomplete registration 
of births and deaths. 
(ii)  Political status of Serbia, Montenegro and Kosovo: Separate data for Serbia and 
Montenegro are not yet available in most international databases since it is only in 
2006 that Montenegro gained independence. There is also no information available 
for Kosovo in these databases due to its current status as an autonomous province. 
Data for Serbia, Montenegro and Kosovo, then, are predominantly drawn from World 
Bank documents, such as health sector notes and public expenditure and institutional 
reviews.  
(iii)  Data vintage: For most analyses, this report uses 2004 data, which is the latest year 
for which validated data are available in most international databases. If earlier or 
later estimates are used, this is stated.  
(iv)  Consistency of estimates across sources: For some indicators, the international 
databases contain different estimates for the same year. In addition, the EU, EU-15 
and EU-12 aggregate estimates that are produced by the WHO HFA-DB 2007 and 
World Bank WDI 2007 databases sometimes differ since the former uses population-
weights in compiling its estimates, while the latter bases its weights on the 
denominator. In the event of inconsistencies across databases, we favored the 
estimates in the World Development Indicators 2007 over other databases, and 
estimates in World Bank publications over estimates in the publications of other 
institutions.  
 
Because of these limitations, although data are drawn from the sources thought to be most 
accurate, they should be interpreted only as indicative of broad trends and of major differences 
across countries rather than as providing precise quantitative measures of those differences. 
 
C. ENSURING SUFFICIENT REVENUES 
 
The relative importance of payroll taxation and general revenues in the financing mix is one of 
the most common distinctions made between healthcare systems. In pure Bismarckian systems, 
the dominant sources of financing are employer and employee contributions, levied as a 
proportion of payroll, and pooled in social health insurance funds. At the other end of the 
spectrum, pure Beveridge systems are funded from general revenues with universal entitlement to 
a fairly comprehensive range of services, at least in Western Europe.  
 
The health system of the former Yugoslavia, referred to as the Stampar model, was unique in 
Eastern Europe because it was funded from compulsory social insurance contributions rather than 
the state budget
7. This financing mode persists in the new states and social health insurance is the 
dominant form of health financing in Macedonia, Serbia, Montenegro, and Bosnia and 
Herzegovina. The heritage of Albania’s healthcare system is very different. Based on the former 
Soviet Semashko model, it was historically funded directly from the central government budget, 
with central health allocations for different health inputs and for each health care institution made 
according to population-based norms. Health insurance was only introduced in 1995 and does not 
play as prominent a role in health financing as in other countries of the sub-region.  
                                                 
7 The Stampar model, named for Croatian specialist in social medicine Andrija Stampar, emphasized 
primary health care and community-based medicine, encouraging family practice as a recognized 
specialization of medicine.   6
  
Social health insurance, as it is implemented in the sub-region, is similar to social health 
insurance in most of the EU-15 countries:  
 
In the countries of the former Yugoslavia, there are publicly-financed and administered extra-
budgetary health insurance funds that are responsible for overseeing and implementing both 
compulsory and any voluntary health insurance schemes. One characteristic of the systems is a 
purchaser-provider split – health insurance funds collect and pool insurance contributions
8 and 
then contract with public, and sometimes private, providers to deliver health services. In Albania, 
on the other hand, the purchaser-provider split is still evolving. Albania’s Ministry of Health 
exercises considerable control as both a financier and provider of health services: health services 
are directly financed through the state budget based on inputs (e.g. salaries), local governments 
administer primary health care, and the health insurance fund (a quasi-autonomous public 
agency) is slowly being granted control over health financing and contracting.  
 
Another characteristic of the systems of the sub-region is the notion of a single-payer – the 
national health insurance fund is the only purchaser in the healthcare system, which is intended to 
lower administrative costs and enable it to leverage its monopsonistic power to purchase services 
from health care providers. 
 
C1. Sources of healthcare revenues 
 
Recognizing that, eventually, with the exception of donor funds, all healthcare funding originates 
with the individual, three main financing sources can be identified in the health sector. These 
include social health insurance (i.e. compulsory contributions in the form of payroll taxes), 
governmental revenues (in the form of direct and indirect taxes) and out-of-pocket payments 
(paid directly by the patient at the point of service). Out-of-pocket expenditures may be in the 
form of co-payments or co-insurance – paid for services partially covered by health insurance and 
designed to discourage unnecessary healthcare consumption – or in the form of full cash 
payments – by the uninsured or for services that lie outside the benefit package. In some 
countries, out-of-pocket expenditures may be inflated by informal payments to healthcare 
providers. Informal payments are usually defined as payments in cash or kind that recipients are 
not authorized to receive under the conditions of their contract or under the statutes of the 
governing bodies of their parent organizations (Chawla 2005), but in some places, informal 
payments can also take the form of genuine gifts given by patients to providers in appreciation of 
their services.  
 
A fourth potential source of financing is voluntary health insurance which can be provided by the 
public insurance provider or by private insurance companies. Voluntary health insurance may be 
of the substitutive type, where it is offered as an alternative to mandatory social health insurance 
for at least a portion of the population; or complementary, to cover the cost of co-payments; or 
supplementary, to cover health care services not included in the standard benefits package. Donor 
funds are a fifth source of financing, but its share of total healthcare financing in the sub-region is 
small and has been declining.   
 
                                                 
8 In Bosnia and Herzegovina, the collection and pooling functions are separated and performed by different 
institutions: the national taxation authority and some cantons collect contributions, and there are multiple 
health insurance funds at different levels of government where contributions are pooled   7
Systems that rely more heavily on public funding tend to do better at attaining health system 
objectives such as financial protection, equity in finance, and equity in utilization (WHO/EURO 
2006). The share of public healthcare financing, including both social health insurance and 
general revenues, in total healthcare revenues is substantial in at least some countries of the sub-
region, and in 2005 was equivalent to around 70% in Macedonia as well as in Serbia and 
Montenegro. Still, this was less than the share of public resources in the comparator countries of 
Croatia and Slovenia (81% and 77% respectively). Almost all remaining healthcare expenditure is 
in the form of private out-of-pocket expenditures. In Albania and in Bosnia and Herzegovina, 
more than half of total healthcare financing is in the form of out-of-pocket payments made by 
households (see Figure 1), potentially rendering the health systems in these countries less 
accessible to the poor. 
 
 














SHI General revenues OOP Private insurance NGOs
Source: WHO NHA database
9, 
Note: Exact figures are provided in Appendix III; the definition of “private insurance” includes all prepaid, private risk-
pooling plans; Kosovo data are for 2004 and the figure does not show the 2.1% of donor funding received in that year.  
 
In all the countries of the former Yugoslavia, payroll taxation is a major source of financing and 
most public expenditure on health flows through the health insurance funds (see Table 1). This 
includes both monies collected as payroll contributions to the health insurance funds, as well as 
transfers to the health insurance funds from extra-budgetary funds, e.g. from pension and 
unemployment funds to cover the health insurance contributions of the pensioners and the 
unemployed. In 2005, according to WHO National Health Accounts data, this was equivalent to 
about 96% of public health sector resources in both the FYR of Macedonia and in Bosnia and 
Herzegovina. In Serbia and Montenegro, the share was a little lower at 76%
10. These percentages 
are in the same range as the share of social health insurance in public revenues in Croatia and 
Slovenia, the two republics of ex-Yugoslavia that have made most progress in health sector 
financing reform. In Albania, despite a mandatory contributory health insurance scheme, social 
health insurance funded only 25% of public health sector expenditure with the rest coming from 
general revenues. While Kosovo has drafted a health insurance law, there is not yet a health 
insurance fund in the country and all health expenditure is financed from the general budget and 
                                                 
9 Note that these are estimates and, with the exception of Serbia, none of the countries in the sub-region 
have developed and institutionalized a National Health Accounts system.  
10 According to World Bank estimates, 90 percent of public health expenditure in Serbia in 2005 was in the 
form of payroll contributions paid to the HIF.   8
user fees, with some additional, but declining, off-budget donor support (equivalent to 2.1% of 
total health expenditure in 2004)
11.  
 
Table 1 Share of public health sector revenues from social health insurance contributions 
and general revenues, 2005 
  Social health insurance  General revenues  Total 
Albania 24.8  75.2  100 
Bosnia and Herzegovina  95.6  4.4  100 
Macedonia, FYR  96.1  3.9  100 
Serbia and Montenegro  75.7  24.3  100 
Kosovo 0  100  100 
Croatia 88.3  11.7  100 
Slovenia 91.4  8.6  100 
Source: WHO NHA database 
 
Private, voluntary health insurance is not well-developed in the Western Balkans. Serbia is the 
only country in the sub-region where private insurance schemes constitute a significant, if small, 
share (3%) of total healthcare revenues. There, the Health Insurance Act of 2005 allowed for the 
development of voluntary health insurance of a substitutive or complementary type, but the 
number of subscribers is small and concentrated in large cities. A limited number of commercial 
insurers are also active in Bosnia and Herzegovina, and the FYR of Macedonia and Montenegro 
have a legal framework in place that will facilitate the insurance market’s emergence 
(Langenbrunner et al. forthcoming). In all countries, however, there are some major obstacles to 
the development of private voluntary health insurance. Most prominent among these are the 
generous benefit packages offered by compulsory health insurance, the fairly limited number of 
private providers that can offer alternative care, and low co-payments – all of which reduce the 
incentives to develop supplementary and complementary insurance plans.  
 
Over time, there have been marked shifts in the composition of revenues. These shifts have not 
exhibited a uniform pattern across countries, though (see Figure 2), and it is not possible to 
identify a particular trend. In Albania, the share of out-of-pocket expenditures has fallen slightly, 
and the share of social health insurance has grown. In Bosnia and Herzegovina, the share of 
general revenues has dwindled, while the shares of social health insurance and out-of-pocket 
expenditures have grown by similar amounts. The opposite pattern is observed in Serbia and 
Montenegro where, following a fairly volatile period (due, in part, to conflicts in the region and, 
in part, to health sector reforms), by the end of the decade, general revenues had become a far 
more important financing source than ten years earlier, at the expense of the role played by social 
health insurance. The emerging importance of private health insurance as a source of financing in 
Serbia is also captured by the data. There has been very little change in the composition of 
financing in the FYR of Macedonia. 
 
                                                 
11 Discussion is ongoing as to whether social health insurance would be the best type of financing for the 
health sector in Kosovo.   9
Figure 2 Trends in the composition of revenues 
 
Source: WHO NHA database 
 
As with most social health insurance schemes elsewhere in the world, contributions to health 
insurance funds in the sub-region are not related to individual or group risk, but are levied on 
earned income. They are compulsory for most employed groups, and are typically shared between 
the employee and the employer. The greatest share of healthcare funding is collected through 
compulsory payroll taxation, but there is also a direct transfer of contributions from the state 
budget to the health insurance funds on behalf of particular categories of people who are exempt 
from making contributions and to finance special programs and the administrative costs of the 
Ministry of Health.  
 
In the countries of the former Yugoslavia, where payroll contributions account for at least three-
quarters of health sector revenues, health insurance contribution rates paid by formally employed 
workers are high, between 15 and 17% of payroll (see Table 2). Albania, where payroll taxes 
account for only 25% of health sector revenues, is entirely different: health insurance 
contributions amount to only 3.4% of wages, shared equally between the employer and the 
employee. This pattern reflects Albania’s heritage because countries of the former Soviet Union 
typically set the level at around 2-4% of payroll.  
 
There is no consistent pattern in the sub-region regarding the employer-employee share of the 
burden of taxation. While both are equally taxed in Albania, Montenegro and Serbia, in the FYR 
of Macedonia the employer pays the total cost of the health insurance contribution and in both 
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SHI General revenues Private OOP Private insurance NGOs  10
the self-employed tend to face lower contribution rates than salaried workers in the public and 
private sectors.  
 
Many categories of labor force participants are exempt from paying contributions. The state 
budget transfers money to the health insurance funds to cover certain vulnerable groups, such as 
the disabled and war veterans. The unemployed and pensioners either have insurance 
contributions paid on their behalf by the unemployment and pension funds or are covered by 
budgetary transfers.  
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1993 15%  payroll 
(15%:0) 
 
18% of income 
Farmers: 15% of 
income if in VAT 
system, or 7.5% 
of income 
estimated based 
on land ownership 
18% of gross pension and 
other benefits plus central 
budget and county budgets 
Slovenia  1993  13.25% payroll  13.25% of  
income 
Central budget. 
Source: Langenbrunner et al. (forthcoming)  
 
C2. Challenges ahead 
 
In all countries of the sub-region (with the exception of Kosovo), it is the health insurance fund 
that pools revenues for health, regardless of whether the source of those revenues are payroll 
taxation or general taxation (i.e. central budget transfers). The flow of revenues from these 
primary revenue streams to the health insurance fund has been unreliable, and together with 
escalating expenditures, has resulted in repeated annual deficits and chronic arrears (see section   11
D1.5). This is due to a number of factors. Some factors are related to the flow of contributions 
from employer- and employee-funded health insurance, and include the labor market structure 
(specifically, widespread unemployment and a large informal sector which narrow the 
contribution base), the large number of categories of the population that are formally exempt 
from making contributions, and the evasion of contributions by those who are legally obliged to 
pay, partly due to poor collection enforcement mechanisms. In addition, budgetary transfers to the 
health insurance funds to cover, among other things, the contributions of exempt populations are 
not always sufficient. Another factor affecting revenue flows to the health sector is the fees 
charges levied at the point of service: users tend to be charged low co-payments, many categories 
of people are exempt from making co-payments, and a fairly wide range of health services do not 
have co-payments associated with them.  
 
C2.1 Limited formal employment growth and high levels of informal employment 
 
The sustainability of healthcare financing is affected by the structure of the labor market. Social 
health insurance works best in economies with high levels of formal employment, and thus large 
payroll contribution bases, and efficient administrative systems that facilitate the payment of 
contributions.  
 
Unemployment rates are high in all countries of the sub-region, except Albania, and employment 
tends to be of a long-term nature. No country approaches the target of a 70% employment rate 
outlined in the European Employment Strategy. Rather, a large share of the active labor force 
works in the informal sector where contributions to health insurance are not made. Another 
segment of the population is formally self-employed and, therefore, responsible for making their 
own contributions, but compliance among this group is not effectively enforced. It is particularly 
difficult to collect contributions from farmers, and especially subsistence farmers, because of the 
difficulties associated with assessing their incomes. As a result, active health insurance 
contributors often account for a relatively small share of the active labor force.  
 
In economies with this labor market structure, and where the link between entitlement to services 
and payment of contributions in weak, a reliance on payroll taxes is likely to result in the demand 
for services exceeding the resources that are available to finance them.  
  
   12
Table 3 Labor market indicators, Western Balkans, 2004 













Albania 63.7  %  60.1%  5.6%  68.4%  76% 
Bosnia and 
Herzegovina  59% 46%  22%    42% 
Kosovo n.a. n.a.  50%
14 n.a.  n.a. 
Macedonia, FYR  51.2%  32% 37.2% 84.5%  n.a. 
Montenegro 65.1%  40.6%  23%  85%  27% 
Serbia   66.6%  53.5%  19.5%  71%  35% 
Source: ILO for Macedonia; World Bank estimates for other countries 
Note: Most estimates are based on household surveys; for Montenegro, data are based on the registered unemployed; 
all Kosovo figures should be treated with skepticism due to the poor availability of data. 
 
C2.2 Limited scope to raise social health insurance contributions 
 
In general, financial planning with respect to contribution rates is poor, and contribution rates are 
still not set according to an actuarial analysis of expected costs and revenues for the insured 
population. Rather, contribution rates tend to be based on a combination of estimates of desired 
revenues (which may or may not reflect the actual revenue that can feasibly be collected given the 
challenges outlined above) and an assessment of the political acceptability of adding to an already 
high tax burden (Langenbrunner et al. forthcoming).  
 
There does not appear to be much scope to raise health insurance contributions in future. With the 
exception of Albania, contribution rates are already very high, and comparable to those in the 
EU-15. The situation is further constrained by the fact that other forms of payroll taxation are also 
high. In Serbia, for example, there is an effective 36% social tax on wages, including health 
insurance contributions of 12%, pension contributions of 22% and unemployment contributions 
of 1.5%.  
 
High labor taxes are a brake on employment expansion. Indeed, one question that arises is 
whether the current high unemployment levels are partly the result of these high levels of payroll 
taxation. Although in theory, and in the long run, a tax on wages would be shifted onto 
employees, in countries where product and labor markets are not very competitive, employers 
may not be able to reduce wages to compensate for an increase in payroll contributions in the 
short run (Gottret and Schieber 2006). Therefore, payroll-financed health contributions may 
increase labor costs and, in turn, lead to higher unemployment. They may also reduce 
competitiveness of the country and deter further investment. 
  
C2.3 Widespread formal exemptions from the payment of social insurance contributions  
 
In addition to informal sector workers, many categories of labor force participants are exempt, by 
law, from paying contributions to the health insurance fund. These groups may include both 
                                                 
12 The long-term unemployment rate is the percentage of the unemployed that have been unemployed for 
12 months or longer. 
13 Definitions of the informal employment rate vary by country. 
14 While the official unemployment rate in Kosovo is around 50%, World Bank estimates that take into 
account seasonal and informal employment place the unemployment rate within the 23%-33% range.   13
active labor market participants and inactive members of designated vulnerable groups such as 
the elderly and disabled. In Albania, for example, formally exempt categories of the population 
include pregnant women, war veterans, the disabled, the unemployed, recipients of social 
assistance, cancer patients, conscripts and pensioners. In Bosnia and Herzegovina, pensioners, the 
disabled, the unemployed, refugees and people with foreign insurance are exempt. 
 
Although these groups are exempt from making contributions, they are still entitled to the 
services that form part of the benefit package. Since the percentage of the population that falls 
into one of the exempt categories tends to be very large – in Bosnia and Herzegovina, for 
example, about half of those who receive health insurance coverage are exempt from paying 
contributions – there is a potential threat to the financial position of the fund. To cover the 
potential funding shortfall, the government typically undertakes to make contributions on behalf 
of these workers by way of transfers either from general revenues or from extra-budgetary funds 
(for example, from pension funds and unemployment funds). However, these contributions are 
not always designed to be equivalent in magnitude to the contribution rates paid through payroll 
taxation for health. Also government ministries sometimes fail to fulfill their agreement to pay 
the defined contribution amounts for the vulnerable groups that are exempt from contributions. 
This typically leaves the health insurance funds facing deficits.  
 
C2.4 Evasion of contribution payments 
 
While contributing to national health insurance funds is compulsory for most categories of 
employed and self-employed workers in the sub-region, there is a risk that both employers and 
employees will evade contributions unless the proper control mechanisms are in place.   
 
For employers, high contribution rates create a strong incentive to avoid making contributions on 
their employees’ behalf. In the FYR of Macedonia, for example, where the employer bears the 
entire burden and, consequently, faces the highest employer contribution rates in the sub-region, 
it is estimated that, of the 8% of the population that do not contribute, most are formal sector 
workers whose employers fail to pay in contributions on their behalf. 
 
For employees, the incentive to contribute depends not only on the contribution rate, but also on 
the size of the benefit package and the extent to which failure to contribute results in one being 
excluded from receiving benefits. Where benefit packages are less generous, the incentive to 
contribute to health insurance is small. In many countries, the link between contribution and 
entitlement is weak and, since those who evade contributions can still collect benefits, tax evasion 
is rife. This is the case in Serbia where, despite a contributory social insurance system, there is, in 
practice, universal health coverage. In 2004, for example, the self-employed and farmers in 
Serbia contributed only 5% and 0.78% of total HIF revenues, far less than their population share.  
 
Underlying tax evasion by both employers and employees are problems of information and 
enforcement. Those with incentives to evade taxes would not be able to do so if collection 
authorities could obtain information on evaders and enforce the payment of contributions. Most 
health insurance funds do not have information systems that would allow contributions to be 
linked to a beneficiary database. This limits their ability to control the collection of contributions 
and enforce payments from private employees, including the self-employed and farmers. Even if 
tax evaders could be identified, punitive measures are weak. 
 
The incentives of the collecting agent also play a role in determining the extent to which 
contribution collection is enforced. In most countries in the sub-region, the health insurance funds   14
are the collecting agents. Bosnia and Herzegovina, however, has moved the collection function 
from the health insurance fund to the national tax authority. It is believed that this move 
substantially reduced the incentive to collect contributions because the link between collection 
efforts and revenues was broken (Langenbrunner et al. forthcoming) and the taxation authority 
lacks the power and inter-ministerial coordinating ability needed to impose sanctions on firms 
and workers that do not pay contributions. Recent data reveal that in Bosnia and Herzegovina, 
collection rates vary from 30% to 84% across cantons. 
 
C2.5 Co-payment policies: widespread exemptions, low levels of co-payments and poor collection 
 
One revenue source is the charges levied at the point of service, whether these are co-payments 
for services covered by health insurance, fees for services provided to those who are not covered 
by insurance, or fees for services that lie outside of the benefit package. The purpose of such fees 
is generally twofold: first, to generate revenue, and second, to curb excess demand for services by 
combating moral hazard. 
 
Out of equity concerns, the countries in the sub-region allow exemption from co-payments or 
reduced co-payments through either income-testing or categorical targeting of people who are 
more likely to be poor, such as the elderly. Exemptions from co-payments are also often 
introduced for particular categories of health services for which it is desirable to induce demand, 
such as immunization, treatment of infectious diseases, and other preventive care. 
 
However, co-payment exemptions that are too widespread and co-payment levels that are too low 
may threaten the financial sustainability of health insurance funds and health systems. In the FYR 
of Macedonia, it is estimated that, at any given time, almost 50% of the population is exempt 
from co-payments and in Serbia, prior to co-payment reform, about 65% of the population was 
exempt from co-payments, although this has now been reduced to about 25% (through removing 
exemptions for the registered unemployed, most age-based exemptions, and exemptions for 
particular categories of diseases).  
 
In those countries, such as Macedonia and Albania, where health care providers are required to 
submit the co-payments that they collect to the health insurance funds, the poor revenue stream 
flowing from co-payments is further reduced by weak collection incentives. Since the budget of 
an individual institution is not affected by the volume of fees collected, there is not a strong 
incentive to collect co-payments. Alternatively, it may create an incentive for the provider to 
collect, but not to remit, the fees. In Macedonia, for example, Health Insurance fund (HIF) data 
show that while 96.4% of the co-payments that should have been collected by the healthcare 
providers were collected, only 8.1% of these co-payments were remitted to the HIF. To better 
align incentives, Macedonia intends to change its policy from 1
st January 2008 so that providers 
can keep the co-payment income. 
 
D. ENCOURAGING EFFICIENT EXPENDITURES 
 
Achieving health system objectives requires substantial expenditure. In order to contain these 
expenditures and maximize their impact, it is essential that money is spent efficiently.  
 
In this section, we describe the current levels of health expenditure, trends in expenditure 
patterns, and the allocation of expenditure across different healthcare categories. Then we discuss   15
how the current levels of expenditure and particular patterns of allocation are driven by the mix of 
incentives created by the structure of the healthcare financing system, such as the provider 
payment mechanisms, the pharmaceutical procurement and pricing systems, the nature of the 
benefits package, and the human resource policy, among other factors.  
 
D1 A large share of national resources are allocated to healthcare expenditure 
 
An analysis of healthcare expenditures in the Western Balkans reveals that total healthcare 
expenditure (as a share of GDP) in the sub-region is similar to that in EU countries. However, the 
proportion of this expenditure that can be attributed to private spending is much larger than in the 
EU. Still, these expenditure levels translate into only small per capita levels of expenditure, even 
when the figures are adjusted for purchasing power parity. Also, while aggregate public 
expenditure is in line with EU and EU-15 levels and per capita spending levels are low, there is 
no fiscal space to increase public expenditures since healthcare already absorbs a large share of 
total government expenditure. 
 
D1.1 Current expenditure levels as share of GDP are aligned with EU countries 
 
The share of GDP allocated to healthcare by countries of the Western Balkans tends to exceed 
that of most other lower middle income countries and, instead, is on par with that of many of the 
EU members (see Figure 3). The total share of GDP spent on healthcare is lowest in Montenegro 
(6.6%) and Albania (6.7%), but health shares in the FYR of Macedonia, Kosovo and Bosnia and 
Herzegovina exceed the average expenditures of the EU-12. Total health expenditures, as a 
percentage of GDP, are highest of all in Serbia (10.6%), exceeding the EU and EU-15 averages of 
9.2% and 9.3% respectively.  
 
While total healthcare expenditure in the sub-region is comparable to EU countries, the share of 
public expenditure is lower (with the exception of Serbia), meaning that private out-of-pocket 
expenditures account for an unusually high share of total expenditure – much more than in the 
European Union and comparator countries. Moreover, there is reason to believe that, at least in 
some cases, private healthcare expenditure in the sub-region tends to be under-estimated by 
official data. In the FYR of Macedonia, for example, the use of Household Budget Survey data 
increases the private expenditure estimate by a whole percentage point. This may be due, at least 
in part, to the incidence of informal payments, as much as to limitations of official data sources.  
 
Across the sub-region there is a fair amount of variation in the mix of public and private 
expenditure. While in the FYR of Macedonia, Serbia and Montenegro, health expenditures are 
financed mainly from public sources, as in most other EU countries, in Bosnia and Herzegovina 
public and private shares are very similar and in Albania private expenditures slightly exceed 
public expenditures.  
   16


















































































































Source: WDI database 2007 for Albania, the FYR of Macedonia, Bosnia and Herzegovina, Croatia, Slovenia and the 
EU aggregates; World Bank estimations for Serbia, Montenegro and Kosovo.  
Note: Data are ordered in ascending magnitude of total health expenditure; for Kosovo, 2004 amounts are 
underestimated due to incomplete reporting of donor off-budget spending; the EU aggregate data are GDP-weighted.  
 
Due to small per capita incomes, these high percentage expenditures translate into low levels of 
per capita expenditure (see Figure 4). In particular, in 2004 per capita expenditure in the Western 
Balkan countries ranged from approximately $100 (Kosovo) to $300 (Serbia) in current US 
dollars. Expressed in PPP-adjusted terms, this is equivalent to around $400 (for those countries 
for which PPP-adjusted data are available). Compared to levels in the rest of the European Union, 
per capita expenditure levels within the sub-region are very similar to each other. 
 
Not only are per capita expenditures levels in the region fairly similar to each when compared to 
other countries, they are also very low. In 2004 dollar terms, per capita expenditure in the 
Western Balkans in 2004 was less than one-tenth of that in countries in the European Union and 
less than half of that of new EU entrants (i.e. the EU-12). While some share of the difference in 
expenditure levels between EU-15 countries and the Western Balkan countries can be explained 
by differences in purchasing power, per capita expenditure figures for the countries of the sub-
region remain around half of the average of the new EU entrants and about a sixth of that of the 
EU-15, even when the figures are adjusted for purchasing power.  
 
Per capita expenditure levels have been increasing over time, however. With the exception of 
Bosnia and Herzegovina, the increase in PPP-adjusted per capita expenditure has either kept pace 
with or exceeded the average EU increase of 33% observed between 1999 and 2004. Still, 
increases are lower than the 51% average increase observed across the new EU entrants.  
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Figure 4 Per capita health expenditure (in current US$ and PPP$), 2004, and change in per 










































































































































Current US$ PPP$ % change 1999-2004, PPP$
Source: WDI database 2007 for current US$ figures and WHO HFA-DB 2007 for PPP$ figures for Albania, the FYR 
of Macedonia, Bosnia and Herzegovina, Croatia, Slovenia and the EU aggregates; World Bank estimates for Serbia and 
Kosovo  
Note: Countries are ordered by increasing magnitude of per capita expenditure in current US$; EU aggregates are 
population-weighted 
 
D1.2 The share of resources spent on health has not increased over the past decade 
 
The expenditure patterns described in the previous sections have had a certain amount of 
durability. Despite the fact that real total health expenditures have increased substantially over 
time, there is evidence of spending containment. With the exception of Albania, the rate of 
increase of health expenditures has been lower than the rate of growth of the economy and, when 
expressed as a percentage of GDP, total health expenditure has, in fact, fallen slightly over time 
in the sub-region. The downward trend appears to have been equivalent to about 1 percentage 
point of GDP over the last decade. This is in contrast to the slightly increasing expenditures that 
have been observed in Slovenia and also elsewhere in the EU. Among the comparators, it is only 
in Croatia that health expenditures as a share of GDP have declined over the past decade (see 
Figure 5). 
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 Figure 5 Trends in total health expenditure (as percentage GDP) in the Western Balkans 
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Source: WHO NHA database (for Western Balkans, Croatia and Slovenia) and WHO HFA-DB 2007 (for EU, EU-15 
and EU-12) 
 
D1.3 The fiscal space to increase expenditures is extremely limited 
 
Fiscal space can be defined as “the capacity of government to provide additional budgetary 
resources for a desired purpose without any prejudice to the sustainability of its financial 
position” (Heller 2006). While current per capita healthcare expenditure is low, it appears that – 
at least for the countries for which data are available – the fiscal space for additional expenditures 
on health is very limited. Most countries in the sub-region already spend a large proportion of 
their public budgets on health. In 2002, the FYR of Macedonia and Serbia and Montenegro 
allocated the same share of government expenditure to health as Croatia and Slovenia did (i.e. 
14%), even though the latter had tremendously higher levels of per capita expenditure (see Table 
4). In addition, all countries in the sub-region spent the same or greater share of total government 
expenditure on health as the EU-15. This means that if health systems in the sub-region are to 
expand the quantity and quality of services offered to their populations, the resources for that will 
need to be sought through either (i) sustained economic growth that generates formal employment 
and increases total public sector resource availability, or (ii) increasing the cost-effectiveness and 
efficiency of existing health sector program. It is only Albania that stands out, allocating half of 
the budgetary share to health that other countries do.    19
 
Table 4 Public expenditure on health as percentage of total government expenditure 
 Value  Year 
Albania 7.3  2001 
Bosnia and Herzegovina  12.8   Average of 1996-2002 
Macedonia, FYR of  14.4  Average of  1996-2002 
Kosovo 11.5  2004 
Serbia and Montenegro  14.0  Average of  2000-2002 
Croatia  13.6  Average of  1996-2002 
Slovenia  14.4  Average of  1996-2002 
EU-15  12.9  Average of  1996-2002 
Source: IMF Government Finance Statistics; Bank estimates for Kosovo 
 
D1.4 The functional composition of public expenditure is marked by inefficiencies 
 
While strict cross-country comparisons are not possible since categories of expenditure in 
available data sources differ across countries
15, it is clear that the composition of health care 
expenditure is skewed towards inpatient care. Typically, such an imbalance results in a crowding-
out of expenditure on outpatient and preventive care – care that is typically more cost-effective. 
Still, the ratio of inpatient to outpatient care, in most cases, is not that much higher than in the 
EU-15 and OECD countries. As a percentage of total public spending on health, the EU-15 
spends about 38% on inpatient care and 31% on outpatient care. The ratio is identical in OECD 
countries which, on average, allocate most of their health expenditure to inpatient care (38%), 
followed by outpatient services, including ancillary services and homecare (31%) (Orosz and 
Morgan 2004). Very similar ratios are observed in the Federation of Bosnia and Herzegovina and 
in Montenegro. In the FYR of Macedonia and Republika Srpska, though, the percentage of the 
health insurance fund budget spent on inpatient care is almost 10 percentage points higher than in 
the EU-15 and in other countries of the sub-region.   
 
Pharmaceutical expenditures are also very high and an important driver of medical inflation (see 
next section)
16. Also, actual total expenditure on drugs are higher than these figures reveal 
because most pharmaceutical estimates tend to reflect only outpatient and retail pharmacy drug 
expenditure, and not the large drug expenditures that are incurred while in hospital and classified 
as part of inpatient care expenditure.  
 
While a conclusive statement can not be made since data are not available for all countries, 
capital expenditures in the sub-region tend to be lower than is needed to maintain physical 
infrastructure and medical equipment in good condition and to purchase up-to-date medical 
technology.  
 
                                                 
15 This reflects differences in the national health accounting systems since the standard National Health 
Accounts expenditure reporting methodology is not yet used in most of the countries of the sub-region. The 
one exception is Serbia where a first set of National Health Accounts have recently been completed, 
although the process is yet to be institutionalized.  
16 See the Policy Note on the Pharmaceutical Sector in the Western Balkans for a more in-depth description 
of the expected increase in spending on pharmaceuticals in the sub-region in the next few years.    20
 
Table 5 Health insurance fund expenditures by level of care, percentage, 2002–04 
  Inpatient Outpatient Prescription  Drugs  Capital 
Investments 
Bosnia and Herzegovina         
 - Federation  38  31  7  5 
 - Republika Srpska  51  27  7  2 
Macedonia, FYR  50  19  13  0.36 
Montenegro 39  30  12  4 
Serbia 41  24  12  0.30 
Croatia 45  16  13  n.a. 
Slovenia n.a.  n.a.  n.a.  n.a. 
EU-15 38
a 31  n.a.  n.a. 
Sources: Original data from Health in Transition Reports, OECD health data, and Bank estimates  
Note: EU-15 figure refers to expenditures on inpatient care as a percentage of total public spending on health, and not 
as a percentage of heath insurance fund expenditure.  
 
D1.5 Expenditures have to be better managed to avoid the accumulation of deficits 
  
While there has been some improvement in recent years, in most countries in the sub-region, 
health insurance funds continue to incur repeated deficits which, over the years, have resulted in 
large arrears for the public health sector. Many healthcare institutions, too, are in arrears, with 
substantial accumulated debts to their suppliers.  
 
For example, in Bosnia and Herzegovina, arrears in the health sector amounted to 0.9% of GDP 
in 2004. Arrears were equivalent to 0.5% of GDP in the Federation, but more acute in Republika 
Srpska where, at 1.9% of GDP, they were equivalent to almost one-third of public health 
spending. By far, the major share of arrears was incurred by hospitals.  
 
In the FYR of Macedonia there has been a substantial reduction in arrears owing to the 
introduction of measures such as monthly financial reporting by the health insurance fund and the 
health care institutions; competitive bidding to improve efficiency in the procurement of 
pharmaceuticals; and hard budget ceilings for health care institutions. By the end of July 2006, 
total arrears were approximately US$78 million, which is a 23% reduction on the figures for the 
preceding year. Of the total still owed, 66% is due to debts of the health care institutions and the 
rest to debts of the health insurance fund.  
 
Serbia, too, had persistent health sector deficits, with the arrears of the HIF growing from 7.9 
billion dinars in 2002 to 9.5 billion dinars by the end of 2004. During this period, debts to health 
care institutions increased until they constituted almost half of all debts of the health insurance 
fund. Other arrears of the health insurance fund include accumulated debts in the form of delayed 
sick leave payments to beneficiaries and interest payments (equivalent to 3% of total HIF 
expenditures). In 2006, all arrears were paid off – in a once-off transfer – with the proceeds of 
privatization. Such solutions, although providing temporary deficit relief, do not address the 
underlying causes of the problem.  
 
Montenegro is the one country that has increasingly managed to bring annual health insurance 
fund deficits under control. It has progressively improved the financial position of its health 
insurance fund from a deficit of over 8% at the end of 2001 to a 1% surplus in 2004. 
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D2 Drivers of health expenditure 
 
The data presented in the previous section showed that while total health expenditure in the 
region is lower than in the EU in per capita terms, it is not substantially lower in terms of GDP. 
This means that despite low per capita spending levels and poorer health status indicators, there is 
unlikely to be room to increase expenditures. Rather, spending on any priority areas will need to 
be financed from efficiency gains and savings in current areas of healthcare expenditure, rather 
than additional budgetary allocations to health.  
 
In this section, we examine the main drivers of healthcare expenditure in the sub-region, with a 
specific focus on how to improve the efficiency of those expenditures. In particular, we look at 
the upward pressures on healthcare expenditure that are brought to bear by the current healthcare 
financing arrangements and the behavioral incentives that they have created. 
 
D2.1 Pharmaceutical procurement and pricing systems 
 
The countries of the Western Balkans spend between 12% and 24% of their public health 
expenditure on pharmaceuticals. On a per capita basis, there is much variation in annual 
expenditure levels, ranging from less than USD$30 per year in Albania to around USD$60 in 
Serbia, Montenegro and the FYR of Macedonia
17. While these levels are not excessive compared 
to expenditure levels in OECD countries, where public expenditure on pharmaceutical and 
medical devices averages 21% of public health expenditures (Orosz and Morgan 2004), the 
current procurement and pricing systems result in a number of inefficiencies which drive up costs 
unnecessarily. In the future, the upward pressure on pharmaceutical expenditures may be further 
aggravated by population aging (if one consequence of aging is that the elderly will have a greater 
a number of unhealthy life years than they have now), increases in health system utilization 
(which is one of the goals of health system reform programs in the region), and the development 
of new, potentially more expensive, pharmaceuticals.  
 
                                                 
17 These figures have not been adjusted for purchasing power parity and, if they were, there is likely to be 
less variation across countries.   22
 
Figure 6 Pharmaceutical expenditure in the public health sector as a percentage of total 
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Source: World Bank estimates (for expenditure as a percentage of GDP) and discussions with stakeholders (for per 
capita figures, see Policy Note on the Pharmaceutical Sector in the Western Balkans)  
Note: For expenditure as a percentage of GDP: Data are for most recent year available, usually 2004 or 2005; data for 
Bosnia and Herzegovina reflect total pharmaceutical expenditure as a percentage of total health expenditure; part of the 
variation in expenditure levels across countries may be attributable to difference in definitions of pharmaceuticals; data 
refer to “prescription drugs” in Albania and Serbia, and only to outpatient pharmaceuticals and devices in Macedonia 
and Bosnia and Herzegovina, excluding drugs used in inpatient care. For per capita expenditure: the Bosnia and 
Herzegovina provided by stakeholders is “less than 50” rather than an actual number.  
 
The drug pricing and procurement system not only has implications for the share of 
pharmaceuticals in health insurance fund expenditures (i.e. for public expenditure) but also for 
household out-of-pocket expenditure on health. Pharmaceutical expenditures account for a large 
share of households’ private expenditure on health. According to the FYR of Macedonia’s 2005 
Household Budget Survey, for example, pharmaceuticals are the largest component of household 
expenditure on health (followed by spending on medical services), accounting for three-quarters 
of the health expenditures of the lower 4 quintiles. Poor supply management in pharmaceuticals 
in the public health system can aggravate the situation when it results in drug shortages in the 
public sector and drugs have to be purchased at private pharmacies. In Kosovo, for example, 
households spend an average of 65% of their out-of-pocket health expenditure on purchasing 
drugs that are supposed to be provided free under Kosovo’s essential drug program, but are not 
available in public health centers or hospital pharmacies.  
 
There are many measures that countries in the Western Balkans could consider to improve the 
efficiency of their pharmaceutical sectors. These include both supply-side mechanisms (e.g. price 
controls, positive lists, pre-approval for expensive drugs, competitive procurement and volume 
controls) and demand-side mechanisms (e.g. co-payment for prescription drugs, and budget or 
quota restrictions for physicians) for improving efficiency.  
 
If efficiency gains are to be realized and expenditure contained, an important starting point is to 
ensure that positive lists of the drugs that are covered by health insurance funds have been 
developed. The decision to include new drugs on positive lists should only be taken after careful 
economic analysis of the cost-effectiveness of those medications. Guidelines to help providers 
prescribe drugs on the positive list should be laid down and pharmacists could be encouraged to 
substitute prescribed drugs for generic equivalents included on the list. Where higher cost brands 
(of non-innovative drugs) are preferred by the consumer or provider, health insurance funds   23
should limit reimbursement to the lowest generic equivalent or, at the very least, impose higher 
co-payments. 
 
How drugs are priced is a key driver of pharmaceutical expenditures. Prices for most medicines in 
the Western Balkans tend to be regulated. For single source patented drugs, reference pricing 
schemes are in place that set the domestic price based on prices (and typically the lowest prices) 
in neighboring countries and some EU countries. Countries with reference pricing should ensure 
that this system is used for the entire set of patented drugs included on the positive list. For 
generic drugs, prices tend to be negotiated with the manufacturer and competition among 
manufacturers in the procurement of drugs could be more actively encouraged. One approach 
could be to use competitive tender mechanisms in defining the prices of drugs on the positive list. 
This strategy has enabled Serbia, Montenegro and the FYR of Macedonia to substantially reduce 
drug prices in the public sector. Montenegro’s Health Insurance Fund, for example, spent an 
enormous 30% of total health expenditures on pharmaceuticals in 2002, but following the 
introduction of a sophisticated pharmaceutical information system and an open tender system 
managed to reduce drugs costs by 31% within two years. The introduction of competitive bidding 
for pharmaceuticals in Macedonia is reported to have contributed to a 30% decline in 
pharmaceutical expenditures. One canton in Bosnia and Herzegovina, Tuzla, has also introduced 
an open tender system.  
 
The regulation of pharmacies needs to be strengthened and measures should be taken to enhance 
transparency in their pricing systems. High mark-ups on drugs at the pharmacy level are common, 
and often in excess of levels recommended by health ministries. For example, while Republika 
Srpska uses a system of reference prices based on a generic drug level to define sales prices for 
HIF reimbursable drugs, pharmacies then sell drugs at a price that is about three times above the 
Ministry of Health’s suggested prices. The implementation of a sophisticated pharmaceutical 
information system that links health insurance funds to pharmacies and allows health insurance 
funds to monitor expenditures, such as is in place in Montenegro, could yield substantial 
dividends. Introducing better drug labeling systems could help to combat illegal imports and 
overcharging by pharmacies. A large reform in Albania, for example, was to introduce labels that 
show the retail price, name of the drug, importer and batch number.  
 
The decentralization and fragmentation that characterizes the healthcare system in Bosnia and 
Herzegovina imposes additional costs. There, each of the 13 health insurance funds (including the 
FBH Solidarity HIF and the 12 cantonal HIFs) has its own drug procurement rules, procedures, 
and positive lists. Small procurement volumes with high associated transaction costs result in 
substantially higher prices. There are also sharp geographic inequalities since prices often differ 
substantially across cantons and some cantons are too poor to pay for the more advanced drugs. 
In the FBH, a price-setting system that selects preferred manufacturers and wholesalers in the 
cantons results in substantial geographic price variation with co-payments for the same drugs 
varying between 25% and 100% of drug prices across the cantons and entities. Substantial 
efficiency gains, which would be translated into cost savings, could be realized if a single 
competitive procurement process and a single positive list was established at a more centralized 
level, possibly through the creation of one central drug agency, or at the very least one drug 
agency at each entity level.  
 
Finally, in order to track pharmaceutical expenditures properly, countries should strengthen their 
national health accounts systems. Currently, it is only expenditure on pharmaceuticals that are 
provided by public outpatient providers and reimbursed through the HIF that can be accurately 
monitored. Expenditure on inpatient drugs is usually not counted as pharmaceutical expenditure, 
but rather included together with inpatient costs under “inpatient expenditures”, resulting in an   24
underestimation of total pharmaceutical expenditures. Also, measuring out-of-pocket expenditure 
on any aspect of healthcare is almost impossible without regular, and detailed, household budget 
surveys.   
 
D2.2 Generous benefit packages and increasingly expensive medical technology 
 
In the Socialist Federal Republic of Yugoslavia (SFRY), access to healthcare was a constitutional 
entitlement of all citizens, and benefits were exceptionally comprehensive. Today, healthcare 
benefits at both primary and secondary level remain very generous in Serbia, Montenegro, 
Kosovo, Bosnia and Herzegovina and Macedonia, and typically include a range of non-essential 
services and even non-health benefits. This tends to drive up expenditures by encouraging 
excessive consumption of these services, which are often very expensive.  
 
In Serbia, recent reforms have eliminated coverage for plastic surgery and funeral expenses and 
restricted dental coverage to children, but the package still includes expensive treatment abroad 
and generous sick leave benefits. There is anecdotal evidence that the sick leave provision is 
frequently abused and used to temporarily disguise redundant unemployment. In Macedonia, the 
non-medical benefits of maternity leave and sick leave consume as much as 5-6% of annual HIF 
expenditures. By contrast, in Albania, which does not have the same legacy of generous health 
insurance-related entitlements, the benefit package is more limited.  
 
In all countries, there is a risk that the benefit package will expand in size over time: as medical 
technology advances, there will be a demand for the inclusion of the latest technological 
procedures into the benefit package. This demand will come not only from consumers, but also 
from healthcare providers, especially those who have benefited from more sophisticated training 
and continuing medical education.  
 
Consequently, countries in the region need to move towards defining affordable benefit packages 
that are focused on services provided at the primary and secondary level. This process will 
require a careful analysis of the costs, and cost-effectiveness, of different treatments, and a 
careful analysis of anticipated health insurance revenues. 
 
One reform that countries could consider would be to remove non-medical benefits from the 
health insurance package. These benefits are not included in most EU countries and, in 
comparisons of health care expenditure, artificially inflate the share of GDP devoted to health in 
the Western Balkans. The difference, in the case of Serbia for example, is estimated to be 
equivalent to around 1% of GDP.  
 
With respect to new technologies, it may be prudent for countries in the sub-region to follow the 
example of many EU countries and adopt formalized medical technology assessment (MTA) and 
pharma-economics techniques in evaluating the cost-effectiveness of new technologies before 
giving approval for their inclusion in benefits packages. Currently, decisions tend to be made by 
committees of experts which are typically dominated by clinicians rather than financing experts. 
This could occur in conjunction with reforms that reserve investment in the most sophisticated 
medical technology for tertiary and specialized hospitals, and implement appropriate referral 
systems to ensure that those patients who need the particular technology receive it. This could 
help to prevent unnecessary duplication of equipment and technological investment that is not 
justified by patient loads. 
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D2.3 Salaries 
 
Expenditure on medical and non-medical wages and salaries accounts for a fairly large share of 
total health expenditure, but the share varies widely across the sub-region. The wage bill 
accounted for 48% of public expenditure on health in the Federation of Bosnia and Herzegovina 
in 2006 (World Bank estimates), a similar share in Republika Srpska in 2004 (World Bank 
estimates), 46% in Macedonia in 2005 (WHO HFA-DB 2007), 29% in Serbia and in Montenegro 
in 2000 (WHO HFA-DB 2007), and 35% Kosovo
18 (World Bank estimates). By comparison, the 
wage bill was equivalent to 35% of public expenditure on health in the EU-12 countries in 2004 
(WHO HFA-DB).  
 
Since salaries account for such a large share of total health expenditure they are an important 
determinant of the financial sustainability of health systems and adopting a sustainable human 
resource strategy needs to be an explicit question addressed by ministries of health if costs are to 
be contained. The size of the wage bill is determined both by the number of employees in the 
health sector and by their wages. 
 
Recent data reveal that the number of physicians, and especially the number of nurses, per capita, 
is lower in the Western Balkans than in the EU-15 and EU-12 countries, despite the high share of 
salaries in total public expenditure on health. In Albania and Bosnia and Herzegovina, the density 
of doctors is especially low, at less than half of EU levels. The problem is not the total number of 
physicians but the excessive proportion of specialists. This is because in the past there was a 
tendency to train too many specialist doctors and too few general practitioners, which shifts 
expenditures upwards by providing specialized care to patients who could be treated more cost-
effectively at lower levels of care. In Serbia, for example, two-thirds of medical doctors are 
specialists and only 15% are general practitioners. The cost-effectiveness of the healthcare 
systems of the Western Balkans could be improved by following the OECD practice of increasing 
the number of nurses relative to doctors and allowing nurses to undertake a wider range of 
clinical functions combined with selective referral to specialists. Although an examination of the 
data shows that the doctor-nurse ratios are not, in fact, higher in the Western Balkans than in EU 
countries, nurses in the sub-region often perform a range of ancillary rather than clinical functions 
and their numbers are not, thus, representative of medical and clinical capacity. 
                                                 
18 The Kosovo figure is, in fact, very high if one considers that highly-specialized care is not offered in the 
province.   26
 

































































































Physicians per 100,000 Nurses per 100,000
Source: WHO HFA-DB, 2007 
Note: Data are for 2005, except for the EU-15 and Slovenia where data are for 2004 
 
There is an expectation that there will, in future, be a demand for higher salaries, especially 
among doctors. Wage compression across different medical professions (e.g. doctors, nurses, 
specialists) is typical in the Western Balkans and means that doctors’ salaries are among the 
lowest in Europe, which fuels wage demands and creates an incentive for doctors to emigrate. 
Thus, while expenditure on wages, as a percentage of public spending on health, is already close 
to EU levels, future upward pressure on the wage bill is expected. The example of the EU-8 
countries may be instructive: between 1999 and 2003, the average monthly salary in the Czech 
Republic, Slovakia and Hungary increased by more than the average monthly salary of 
occupational groups with equivalent levels of education and experience (Chawla 2005). 
Moreover, the ratio of physician salaries to national average for these occupational groups in the 
Western Balkans is well below the average ratio of 2 that is observed in EU-15 countries. 
 
Another source of upward pressure on the wage bill is a staffing structure that exhibits large non-
medical (i.e. ancillary) staff to medical staff ratios. In Macedonia, for example, non-medical staff 
account for almost 30% of total staff numbers; in Bosnia and Herzegovina, the figure is 33%. The 
share is slightly lower at around 28% in Serbia and Montenegro, and is being further reduced 
under current reform programs, but is still high compared to the ratios in the EU and comparator 
countries. In the United Kingdom, for example, the figure is only 13%. However, since the 
functions of many ancillary staff working in the United Kingdom and other European health 
systems tend to be contracted out, this figure is likely to substantially underestimate the number 
of ancillary workers in the public healthcare sector in other countries, thus making it very difficult 
to accurately gauge to what extent the non-medical to medical ratio in the Western Balkans really 
exceeds that of the EU. 
 
Improving the efficiency of the health sector will necessarily involve the rationalization of the 
number and type of workers in the health sector, as well as their functions. Serbia, for example, 
has already taken steps to reduce the number of medical and non-medical employees, as part of a 
wider public sector rationalization program 
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Optimizing the staff mix could be facilitated by moving from an input-based hospital payment 
method to an output-based one. The fixed annual budget allocations of the input-based systems 
mean that health care managers have neither the autonomy and flexibility nor the incentives to 
hire and fire workers so as to optimize the staff mix.  
 
D2.4. Excess medical capacity in the hospital sector  
 
The share of health expenditure devoted to the hospital sector in the Western Balkans is high, but 
the sector is marked by low productivity. This takes a number of forms.  
 
Inpatient admission rates are low with the result that available resources, such as hospitals, beds 
and staff, are under-utilized. Annual inpatient admission rates range from 8.7 per 100 people 
Albania to 12 per 100 people in Serbia, compared to 17 in Croatia, 18 in Slovenia, 17 in the EU 
and 21 in the EU-12. Bed occupancy rates in acute care hospitals for those countries for which 
data are available (i.e. Serbia, Montenegro and Macedonia) are between 5 and 10 percentage 
points lower than the EU average of 76%. Moreover, the fact that the patients who are admitted 
seem to have longer-than-average stays in hospital, between 9.5 and 11 days, compared to an 
average of 8 days in EU 10 and 9.25 days in EU as a whole, means that bed occupancy rates are 
higher than they would have been were patients being discharged or moved to outpatient care as 
soon as they could be. Only in Albania is the average length of stay (ALOS) very short, about 6.4 
days. Comparison with data from earlier years suggests that the ALOS has been rapidly 
decreasing, though: between 2000 and 2005, the ALOS fell by at least one day in all the countries 
of the Western Balkans. 
 
With the exception of Montenegro, the number of outpatient contacts per person per year is low 
compared to EU countries. In Albania, the average person utilizes outpatient care only about 1.5 
times per year. This number is higher in Bosnia and Herzegovina (3.3) and in the FYR of 
Macedonia, but well below the EU and Montenegro average of around 7. 
 
Table 6 Inpatient and outpatient health care utilization, 2005 (unless noted otherwise) 
  Bed occupancy rates 





per 100 people 
Outpatient contacts, 
per person per year 
Albania -  6.4  8.7  1.5 
Bosnia and 
Herzegovina 
- 9.6  8.2  3.3 
Serbia 69%*  10.6  12.0 
- 
Montenegro 69.7%*  9.8*  10.7  6.9 
Macedonia, FYR   55.5% 11.1  9.9  4.3 
Kosovo -  -  - 
- 
Croatia 88.1%  10.3  16.6  6.9 
Slovenia 70.1%  7.1  17.6  7.2 
EU 75.9%  9.3*  18.1*  6.8* 
EU-15 -  9.6**  17.5**  - 
EU-12 74%  8.03  20.8  7.9 
Source: WHO HFA-DB, 2007, except for Serbia and Montenegro (World Bank estimates) 
Note: Data are for 2005, unless denoted by an * for 2004 or a ** for 2003 
 
With the exception of Macedonia, all countries have between 1 and 2 hospitals per 100,000 
people compared to an average of 3 hospitals in the EU. Also, compared to the EU average of 585 
beds per 100,000 population, the number of beds in the hospital sectors of the Western Balkans is   28
not completely excessive, and much lower than the group of new EU entrants where the average 
was 644 per 100,000 in 2005 (see Table 8). In fact, the number of beds per 100,000 people in 
Albania and Bosnia and Herzegovina is about half that of the EU. Moreover, it is only in Serbia 
and in Bosnia and Herzegovina that health systems seem to be dominated by a few large hospitals 
with enormous bed capacity. Elsewhere, capacity is very similar to the EU – at least on a 
population-wide basis.  
 
What may be more of an issue is the appropriateness of the distribution of those beds across 
hospital sectors (general, specialized and tertiary care) and across the geographic area of the 
country. Bed numbers in specialized facilities may not necessarily correspond to the specific 
medical needs of the population; the bed numbers may not be located in areas of greatest 
population need while other population groups may have access to a number of medical facilities. 
In urban centers, for example, there are some very large hospitals that account for a large share of 
the total national bed availability, but very little access in rural areas. For example, while 
Macedonia averages 470 beds per 100,000 people, the distribution of these beds is such that bed 
capacity varies between 130 per 100,000 in Kochani and 520,000 per 100,000 in Shtip.  
 
Another major source of inefficiency in health systems is the loss of productivity that can result 
due to underutilization of primary health care facilities, too-frequent referral from the primary 
care level to the secondary and tertiary care levels, and skipping of primary care treatment to seek 
care directly at the secondary and tertiary level. Physicians in Bosnia and Herzegovina, for 
example, only resolve about half of primary health care cases and refer the rest to the more 
expensive secondary and tertiary care, even though such referrals may be unnecessary. One 
contributing factor is the low number of primary health care units in some countries. In Bosnia 
and Herzegovina, Serbia and Montenegro, the number of primary health care units per 100,000 
people is only around 30, which is half as many as there are in the EU-12 countries.  
 
Table 7 Supply of medical facilities, 2005 
 Hospitals   
per 100,000 
Primary Health Care 
units per 100,000 
Hospital beds  
per 100,000 
Albania 1.6  76.55  297 
Bosnia and 
Herzegovina 
0.95 30.28  304 
Serbia 1.38  -  593 
Montenegro 1.93  29.52  418 
Macedonia, FYR  2.65  91.05  470 
Kosovo -  -  - 
Croatia 1.76  74.54  545 
Slovenia 1.45  3.2  483 
EU 3.04  -  585 
EU-15 3.19  -  571 
EU-12 2.63  62.22  644 
Source: WHO HFA-DB, 2007 
Note: Data are for 2005, except for the EU-15 data which are for 2004 
 
To improve hospital productivity, the average length of stay (ALOS) should be shortened, bed 
occupancy rates increased and the number of beds reduced. Further reductions may be possible 
by improving admission management, facilitating earlier discharge and strengthening 
coordination among levels of providers, especially when it comes to moving patients from 
inpatient to outpatient care.  
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Countries could also consider reducing the number of beds, and planning so that the number of 
hospitals and beds is based on the estimated catchment-area population. Moving to a case-based 
payment method (see section D2.5) is one possible way to achieve a more rational allocation of 
beds since hospitals without sufficient cases would be forced to merge with other hospitals or 
close down. Standards of care and decision rules that help to reduce the average length of stay in 
hospitals could be implemented.  
 
D2.5. Line budgeting 
 
Current systems of paying providers, and especially hospitals, do not encourage cost containment 
nor provide incentives for better performance. It is these systems that are, in part, responsible for 
the efficiency problems, such as excess medical capacity and excess staff, discussed in the 
previous sections. 
 
In the sub-region, line budgeting is still the most common provider payment mechanism. In this 
system, the health insurance fund pays providers according to line items, such as wages and 
salaries, utilities, medicines and other supplies, on the basis of an annual contract negotiated 
between the health insurance fund and each provider. Because the budget in one year is largely 
determined by the costs of inputs in the previous year, hospital management has an incentive to 
utilize the entire budget each year rather than to contain expenditures. Also, while the contracts 
between healthcare institutions and health insurance funds may require reports on performance, 
there are typically no penalties associated with poor performance, and hence no accountability. In 
addition, since the budget is related to historical patterns, and not to the number and the severity 
of the cases treated, there is no incentive to treat difficult cases, but rather an incentive to refer 
these cases to higher levels of care. This means that primary care providers do not act as effective 
gate-keepers to higher levels of care. 
 
In the medium-term, countries in the region could consider moving from input-based to output-
based financing mechanisms. A useful starting point may be the implementation of global 
budgeting, which is currently under development in Bosnia and Herzegovina and FYR of 
Macedonia. This is a prospective budget-setting approach that fixes the price as well as the 
volume of inpatient services. A more sophisticated provider payment mechanism would be the 
use of case-based financing based on diagnosis-related groups (DRGs). Most countries of 
Western Europe now use a combination of global budgeting and DRG approach, and a pilot is 
currently underway in Podgorica, Montenegro.  
 
Such reforms will necessarily have to be accompanied by capacity-building in health information 
systems in order to capture the data necessary to make informed decisions about the allocation of 
resources. For global budgeting, and especially for a DRG approach, detailed information on the 
costs of all different resources, as well as data on the different diagnostic groups, will be needed.  
 
E. MOVING FORWARD 
 
Over the past decade, all countries of the sub-region have embarked on a number of reforms 
aimed at improving access to a health system that provides comprehensive quality services and 
protects vulnerable groups from the impoverishing effects of ill-health, while still ensuring the 
systems’ fiscal sustainability. As experience elsewhere in Europe has shown, such reforms are 
technically, institutionally and politically difficult and need to be sustained for extended periods if   30
they are to be implemented effectively (Belli 2001). Clearly, there is no “one size fits all” 
solution, and devising strategies to manage healthcare expenditures will require careful 
consideration of the precise financing mechanisms in place, the macroeconomic context and the 
political climate. However, the following actions can be singled out as necessary elements of a 
successful reform:  
 
Optimize revenue collection. The sustainability of healthcare systems depends largely on the 
ability to generate sufficient revenues. Today many countries in the Western Balkans continue to 
face difficulties in raising revenues, due to high levels of unemployment, informal economic 
activity and poor collection mechanisms. In countries with social health insurance, the aging of 
the population will put increasing pressure on the sustainability of health financing both through 
increased demand for healthcare by the adult population and, most importantly, larger 
dependency ratios and a smaller contribution base. Many countries in Europe that relied only on 
payroll contributions to finance healthcare have begun to revisit their financing arrangements and, 
to different degrees, have started relying more on general revenues. Depending on their 
institutional and fiscal situation, and on their preferences, countries in the Western Balkans 
should also develop an explicit, comprehensive revenue collection strategy that considers all 
available methods, such as direct taxation, indirect taxation, social security contributions, 
voluntary health insurance, and user charges
19.  
 
Rationalize the benefit package. In all Western Balkan countries, benefit packages are very 
comprehensive and, therefore, very costly. In order to eliminate the implicit rationing of health 
care stemming from an unaffordable benefit package – and the associated inefficiencies and 
inequities – it is necessary to align the services provided with the resources that are available. 
This process should involve a review of the size and scope of the package that takes into 
consideration international practices, national demographic and epidemiological characteristics 
and the expected future flow of revenues.  
  
Modernize the healthcare delivery system. The introduction of a new primary healthcare model 
that emphasizes family medicine is proving to be successful in most countries, and is resulting in 
increased patient satisfaction. This should only be the first step, however, towards a more 
profound reorganization process, aimed at eventually making general practitioners the 
“gatekeepers” of the rest of the health system, as part of a larger strategy of optimizing the 
existing network of providers. In order to do so, most countries in the Western Balkans have 
started preparing hospital restructuring strategies (also referred to as Master Plans) to reorient the 
delivery system towards preventive and primary care and to increase the efficiency of the hospital 
network by establishing infrastructure, equipment, staffing and service standards in each facility. 
Politically, this is a very difficult process, and is often in conflict with the interests of physicians 
who tend to be specialists working in larger hospitals.  
 
Engage the private sector. Involving the private sector in both the financing and provision of 
healthcare services needs to be further explored because of the potential efficiency gains and 
greater consumer choice it offers. Involvement can include the provision of private healthcare in 
public or private facilities, which will in turn require a stronger role for government in licensing, 
accreditation and quality assurance. Private health insurance, either as a substitute or complement 
to social health insurance, exists only in Serbia. Public-private partnerships are not yet well-
known in the sub-region. While there is substantial scope for private sector involvement in 
healthcare financing and delivery, successful involvement will require the careful development of 
                                                 
19 See Langenbrunner et al. (forthcoming) for a discussion on the options for sources of health financing 
and revenue collection.    31
an appropriate legal and regulatory framework, and so this is an issue that needs to be integrated 
into the larger debate on healthcare reforms in the Western Balkans. 
  
Strengthen human resource planning and training. As important as the financing and 
organizational reforms are, countries also need to proceed quickly to upgrade the clinical 
management of care. To do so, two types of interventions are particularly important. First, 
providers’ skills ought to be upgraded to reflect state-of-the art medical practice, which relies 
heavily on evidence-based medical and nursing practices. Second, new protocols ought to be 
developed since some of the existing protocols are outdated, especially with regard to the 
promotion of healthy lifestyles, the prevention of non-communicable diseases and outpatient-
based methods of disease management. Continuing medical education, which has been introduced 
as part of the health system reforms in most countries of the Western Balkans, needs to be 
sustained.   
 
Reform the payment system for health providers. The payment system that countries in the 
Western Balkans inherited pays salaries that are based on coefficients defined by the Ministry of 
Health in collaboration with the Ministry of Finance and trade unions of healthcare professionals. 
The system does not grant any substantial financial incentive for the accomplishment of a greater 
volume of work and/or the delivery of more efficient and better quality services. Changing the 
way healthcare providers are paid is the central pillar of reorienting the health system away from 
historical, line item budgeting towards a system that rewards outputs and quality, thereby 
increasing the efficiency of public spending and the sustainability of health financing. Reforming 
the payment system will, however, be a very difficult and lengthy process. One of the biggest 
constraints is the limited capacity for strategic purchasing in most health insurance funds. Most 
countries in the Western Balkans have started or plan to start introducing capitation payments for 
primary health care and case-based payments for secondary and tertiary care. As countries move 
forward with changing provider payment mechanisms, it is crucial to consider individual 
incentives alongside institutional incentives. It is not sufficient to devise ever more sophisticated 
reimbursement systems at the institutional level if employees within these institutions continue to 
receive the same low, productivity-independent salaries. In addition, steps will need to be taken to 
reduce the volume of informal payments made to healthcare providers since they undermine the 
impact of health reforms, siphon funds away from the health system and negatively affect the 
quality of service provided to those who cannot or do not make these payments. 
 
Regulate the pharmaceutical sector. Countries in the Western Balkans have made significant 
progress in modernizing their pharmaceutical sectors. Nevertheless, drug expenditure is set to 
grow in this region as it did in other countries in Eastern Europe, typically at a rate of about twice 
GDP growth, due to inevitable factors such as innovation, aging populations, increasing incomes 
and better access to health care. For the foreseeable future there will be a need for further 
capacity-building in the pharmaceutical sector, with a focus on increased oversight and higher 
professional standards, more efficient use of limited public resources, better drug pricing policies, 
equity in access and the rational use of medicines.  
 
Improve data quality. The paucity of good data with which to track health care expenditure and 
revenue streams, and analyze liabilities, deficits and arrears, is a constraint on countries’ abilities 
to effectively manage their expenditures. An important first step could be to move towards 
institutionalizing systems of National Health Accounts within each country, which would allow 
the analysis of expenditure by combinations of provider type, function and financing source. In 
the Western Balkans, it is only Serbia that has advanced in this process, but first steps towards it 
have been taken in Montenegro and Kosovo. At the level of the individual institutions, the 
establishment of formal and regular financial reporting mechanisms is important. Regular   32
household budget surveys with detailed health budget components would greatly enhance the 
measurement of private out-of-pocket health expenditures. 
 
So far, governments in the sub-region have managed to contain the increases in public spending 
on health within the rate of growth of their economies. At the same time, not only does the fiscal 
space to further increase public spending on health remain limited, but health insurance funds 
have generally failed to keep their expenditures in balance with their revenues, and the health 
system has accumulated substantial debt. If the desired health system goals are to be achieved, 
health system reforms will need to be sustained for extended periods of time. Thus, the Western 
Balkans no longer face the choice of either reforming their health sectors or leaving them 
unchanged. Fiscal pressures make sectoral change inevitable. The real question is whether 
policymakers will allow change to occur in a piecemeal fashion toward uncertain outcomes or 
will instead try to steer it along a sustainable path. 
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Table 8 Share of healthcare financing derived from different sources 





insurance NGOs   
Western Balkans            
Albania 10.8  32.7  56.4  0.0  0.1  100 
Bosnia and Herzegovina  46.6  2.1  51.2  0.0  0.0  100 
Kosovo 0  59.0  61.0  0.0  0.0  100 
Macedonia, FYR of   67.9 2.7 29.4 0.0 0.0  100 
Serbia and Montenegro  52.6  16.9  27.6  2.9  0.0  100 
            
Comparators            
Croatia 71.9  9.5  17.5  1.1  0.0  100 
Slovenia 70.4  6.6  10.0  13.0  0.0  100 
Source: WHO NHA database 
Note: The definition of “private insurance” includes all prepaid, private risk-pooling plans; Kosovo data are for 2004 
and the figure does not show the 2.1% of donor funding received in that year.  
 